The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1
Abstract
PON1 (paraoxonase-1) is an HDL (high-density lipoprotein)-associated enzyme capable of hydrolysing diverse substrates from OP (organophosphate) toxins to oxidized phospholipids. As such, it has been linked with both the prevention of OP poisoning and inhibition of atherosclerosis initiated by oxidatively modified LDL (low-density lipoprotein). Mice deficient in PON1 are more susceptible to OP poisoning and oxidative stress and more prone to develop atherosclerosis than their wild-type siblings. There are a number of polymorphisms in the PON1 gene which affect serum PON1 activity and concentration. Many (but not all) studies in human populations have suggested that these polymorphisms may be a risk factor for atherosclerosis. The serum concentration of PON1 across the general population is highly variable and there is some debate as to whether genotype or phenotype (i.e. the quantity or quality of the enzyme) is most accurately associated with risk of disease development. What is clear is that factors influencing serum levels of PON1, be they genetic or environmental, will, in turn, affect the capacity of HDL to protect LDL from oxidation and, consequently, may be linked to atherosclerosis. This review will focus on mechanisms which determine the serum concentration of PON1, including gene expression and genetic polymorphisms, protein secretion and association with HDL, pharmacological and environmental factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Watson, A. D., Berliner, J. A., Hama, S. Y., La Du, B. N., Faull, K. F., Fogelman, A. M., & Navab, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118359 · Cited by 1,154
Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
MACKNESS, M., ARROL, S., ABBOTT, C., & DURRINGTON, P. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90183-u · Cited by 816
The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family
Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., & Du, B. N. L. (1996) · Genomics · doi:10.1006/geno.1996.0225 · Cited by 673
Harel, M., Aharoni, A., Gaidukov, L., Brumshtein, B., Khersonsky, O., Meged, R., Dvir, H., Ravelli, R. B. G., McCarthy, A., Toker, L., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb767 · Cited by 646
The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin
Davies, H. G., Richter, R. J., Keifer, M., Broomfield, C. A., Sowalla, J., & Furlong, C. E. (1996) · Nature Genetics · doi:10.1038/ng1196-334 · Cited by 603
Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C. L., Newton, R. S., & La Du, B. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00272-x · Cited by 596
Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A., & Aviram, M. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.2744 · Cited by 552
Krieger, M. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.523 · Cited by 519
Garin, M. C., James, R. W., Dussoix, P., Blanché, H., Passa, P., Froguel, P., & Ruiz, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119134 · Cited by 476
Self-citationAviram, M., Billecke, S., Sorenson, R., Bisgaier, C., Newton, R., Rosenblat, M., Erogul, J., Hsu, C., Dunlop, C., & La Du, B. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1617 · Cited by 458
Decreased Atherosclerotic Lesion Formation in Human Serum Paraoxonase Transgenic Mice
Tward, A., Xia, Y.-R., Wang, X.-P., Shi, Y.-S., Park, C., Castellani, L. W., Lusis, A. J., & Shih, D. M. (2002) · Circulation · doi:10.1161/01.cir.0000023623.87083.4f · Cited by 455
Mackness, B., Davies, G. K., Turkie, W., Lee, E., Roberts, D. H., Hill, E., Roberts, C., Durrington, P. N., & Mackness, M. I. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0901.094247 · Cited by 435
Shih, D. M., Xia, Y.-R., Wang, X.-P., Miller, E., Castellani, L. W., Subbanagounder, G., Cheroutre, H., Faull, K. F., Berliner, J. A., Witztum, J. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910376199 · Cited by 425
Pharmacogenetics of paraoxonases: a brief review
Draganov, D. I., & Du, B. N. L. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0833-1 · Cited by 416
Human Serum Paraoxonase (pon1) Isozymes Q and R Hydrolyze Lactones and Cyclic Carbonate Esters
Billecke, S., Draganov, D., Counsell, R., Stetson, P., Watson, C., Hsu, C., & Du, B. N. L. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15082-9 · Cited by 402
Calcium-dependent Human Serum Homocysteine Thiolactone Hydrolase
Jakubowski, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3957 · Cited by 398
Mackness, B., Mackness, M. I., Arrol, S., Turkie, W., & Durrington, P. N. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00064-7 · Cited by 377
Effects of 5′ Regulatory-Region Polymorphisms on Paraoxonase-Gene (PON1) Expression
Brophy, V. H., Jampsa, R. L., Clendenning, J. B., McKinstry, L. A., Jarvik, G. P., & Furlong, C. E. (2001) · The American Journal of Human Genetics · doi:10.1086/320600 · Cited by 368
BLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
Self-citationSorenson, R. C., Bisgaier, C. L., Aviram, M., Hsu, C., Billecke, S., & La Du, B. N. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.9.2214 · Cited by 324
Kaplan, M., Hayek, T., Raz, A., Coleman, R., Dornfeld, L., Vaya, J., & Aviram, M. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.8.2082 · Cited by 318
Wheeler, J. G., Keavney, B. D., Watkins, H., Collins, R., & Danesh, J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15642-0 · Cited by 317
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Jarvik, G. P., Rozek, L. S., Brophy, V. H., Hatsukami, T. S., Richter, R. J., Schellenberg, G. D., & Furlong, C. E. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.11.2441 · Cited by 309
Leviev, I., & James, R. W. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.2.516 · Cited by 308
Self-citationAharoni, A., Gaidukov, L., Yagur, S., Toker, L., Silman, I., & Tawfik, D. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536901100 · Cited by 288
Determination of paraoxonase (PON1) status requires more than genotyping
Richter, R. J., & Furlong, C. E. (1999) · Pharmacogenetics · doi:10.1097/00008571-199912000-00009 · Cited by 281
Li, W.-F., Costa, L. G., Richter, R. J., Hagen, T., Shih, D. M., Tward, A., Lusis, A. J., & Furlong, C. E. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00002 · Cited by 276
Costa, L. G., Cole, T. B., Jarvik, G. P., & Furlong, C. E. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152421 · Cited by 264
Deakin, S., Leviev, I., Gomaraschi, M., Calabresi, L., Franceschini, G., & James, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107440200 · Cited by 251
Self-citationParaoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response
Feingold, K. R., Memon, R. A., Moser, A. H., & Grunfeld, C. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00084-7 · Cited by 248
Shih, D. M., Gu, L., Hama, S., Xia, Y. R., Navab, M., Fogelman, A. M., & Lusis, A. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118589 · Cited by 247
Gouédard, C., Barouki, R., & Morel, Y. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5209-5222.2004 · Cited by 238
Tomás, M., Sentí, M., García-Faria, F., Vila, J., Torrents, A., Covas, M., & Marrugat, J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2113 · Cited by 223
James, R. W., Leviev, I., & Righetti, A. (2000) · Circulation · doi:10.1161/01.cir.101.19.2252 · Cited by 215
Self-citationvan der Gaag, M. S., van Tol, A., Scheek, L. M., James, R. W., Urgert, R., Schaafsma, G., & Hendriks, H. F. J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00243-9 · Cited by 197
Self-citationVitamin C and E Intake Is Associated With Increased Paraoxonase Activity
Jarvik, G. P., Tsai, N. T., McKinstry, L. A., Wani, R., Brophy, V. H., Richter, R. J., Schellenberg, G. D., Heagerty, P. J., Hatsukami, T. S., & Furlong, C. E. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000027101.40323.3a · Cited by 190
Decrease of serum paraoxonase activity in chronic renal failure.
Dantoine, T. F., Debord, J., Charmes, J. P., Merle, L., Marquet, P., Lachatre, G., & Leroux-Robert, C. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v9112082 · Cited by 188
Antioxidant Paraoxonase 1 Activity in the Metabolic Syndrome
Sentí, M., Tomás, M., Fitó, M., Weinbrenner, T., Covas, M.-I., Sala, J., Masiá, R., & Marrugat, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030648 · Cited by 186
Apolipoprotein J Is Associated with Paraoxonase in Human Plasma
Kelso, G. J., Stuart, W. D., Richter, R. J., Furlong, C. E., Jordan-Starck, T. C., & Harmony, J. A. K. (1994) · Biochemistry · doi:10.1021/bi00169a026 · Cited by 179
Nishio, E., & Watanabe, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6961 · Cited by 171
Study of factors influencing the decreased HDL associated PON1 activity with aging
Seres, I., Paragh, G., Deschene, E., Fulop, T., & Khalil, A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2003.08.001 · Cited by 169
Tsimihodimos, V., Karabina, S.-A. P., Tambaki, A. P., Bairaktari, E., Goudevenos, J. A., Chapman, M. J., Elisaf, M., & Tselepis, A. D. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0202.102918 · Cited by 158
Ferré, N., Camps, J., Fernandez-Ballart, J. D., Arija, V., Murphy, M. M., Ceruelo, S., Biarnés, E., Vilella, E., Tous, M., & Joven, J. (2003) · Clinical Chemistry · doi:10.1373/49.9.1491 · Cited by 157
Suehiro, T., Nakamura, T., Inoue, M., Shiinoki, T., Ikeda, Y., Kumon, Y., Shindo, M., Tanaka, H., & Hashimoto, K. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00379-2 · Cited by 155
Simvastatin Modulates Expression of the PON1 Gene and Increases Serum Paraoxonase
Deakin, S., Leviev, I., Guernier, S., & James, R. W. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000096207.01487.36 · Cited by 151
Self-citationPharmaceutical quality of different Ginkgo biloba brands
Kressmann, S., Müller, W. E. G., & Blume, H. H. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021778970 · Cited by 150
Durrington, P. N., Mackness, M., Bhatnagar, D., Julier, K., Prais, H., Arrol, S., Morgan, J., & Wood, G. N. I. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00003-3 · Cited by 145
James, R. W., Leviev, I., Ruiz, J., Passa, P., Froguel, P., & Garin, M. C. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1390 · Cited by 138
Self-citationReduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat
Sutherland, W. H. F., Walker, R. J., de Jong, S. A., van Rij, A. M., Phillips, V., & Walker, H. L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1340 · Cited by 138
Fuhrman, B., Koren, L., Volkova, N., Keidar, S., Hayek, T., & Aviram, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00063-1 · Cited by 133
Opposite Regulation of the Human Paraoxonase-1 Gene PON-1 by Fenofibrate and Statins
Gouédard, C., Koum-Besson, N., Barouki, R., & Morel, Y. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.945 · Cited by 132
Boemi, M., Leviev, I., Sirolla, C., Pieri, C., Marra, M., & James, R. W. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00556-6 · Cited by 130
Self-citationJarvik, G. P., Hatsukami, T. S., Carlson, C., Richter, R. J., Jampsa, R. L., Brophy, V. H., Margolin, S., Rieder, M. J., Nickerson, D. A., Schellenberg, G. D., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000081635.96290.d3 · Cited by 130
Sklan, E. H., Lowenthal, A., Korner, M., Ritov, Y., Landers, D. M., Rankinen, T., Bouchard, C., Leon, A. S., Rice, T., Rao, D. C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307659101 · Cited by 130
Serum paraoxonase activity in patients with type 1 diabetes compared to healthy controls
Mackness, B., Durrington, P. N., Boulton, A. J. M., Hine, D. G., & Mackness, M. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.00977.x · Cited by 129
Ferretti, G., Bacchetti, T., Marchionni, C., Caldarelli, L., & CURATOLA, G. (2001) · Acta Diabetologica · doi:10.1007/s592-001-8074-z · Cited by 127
Pfohl, M., Koch, M., Enderle, M., Kühn, R., Füllhase, J., Karsch, K. R., & Häring, H.-U. (1999) · Diabetes · doi:10.2337/diabetes.48.3.623 · Cited by 125
Lenten, B. J. V., Wagner, A. C., Navab, M., & Fogelman, A. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004074200 · Cited by 123
Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
Paragh, G., Balla, P., Katona, E., Seres, I., Égerházi, A., & Degrell, I. (2002) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060200013 · Cited by 114
Forte, T. M., Subbanagounder, G., Berliner, J. A., Blanche, P. J., Clermont, A. O., Jia, Z., Oda, M. N., Krauss, R. M., & Bielicki, J. K. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30154-1 · Cited by 108
Leviev, I., Deakin, S., & James, R. W. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31161-5 · Cited by 99
Self-citationScharnagl, H., Schinker, R., Gierens, H., Nauck, M., Wieland, H., & März, W. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00790-0 · Cited by 95
Bagdade, J. D., Buchanan, W., Kuusi, T., & Taskinen, M. (1990) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.10.2.232 · Cited by 95
Bennett, M. K., & Osborne, T. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6340 · Cited by 94
Kinetics of HDL Cholesterol and Paraoxonase Activity in Moderate Alcohol Consumers
Sierksma, A., van der Gaag, M. S., van Tol, A., James, R. W., & Hendriks, H. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200209000-00017 · Cited by 88
Self-citationKumon, Y., Suehiro, T., Ikeda, Y., & Hashimoto, K. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00704-5 · Cited by 82
Paraoxonase Activity Is Reduced by a Pro-atherosclerotic Diet in Rabbits
Mackness, M., Bouiller, A., Hennuyer, N., Mackness, B., Hall, M., Tailleux, A., Duriez, P., Delfly, B., Durrington, P. N., Fruchart, J., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2265 · Cited by 79
Low Paraoxonase in Persian Gulf War Veterans Self-Reporting Gulf War Syndrome
Mackness, B., Durrington, P. N., & Mackness, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3526 · Cited by 79
Hedrick, C. C., Hassan, K., Hough, G. P., Yoo, J., Simzar, S., Quinto, C. R., Kim, S.-M., Dooley, A. N., Langi, S., Hama, S. Y., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.8.1946 · Cited by 75
Bonafè, M., Marchegiani, F., Cardelli, M., Olivieri, F., Cavallone, L., Giovagnetti, S., Pieri, C., Marra, M., Antonicelli, R., Troiano, L., et al. (2002) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200806 · Cited by 69
Sentı́, M., Tomás, M., Anglada, R., Elosúa, R., Marrugat, J., Covas, M.-I., & Fitó, M. (2003) · European Journal of Internal Medicine · doi:10.1016/s0953-6205(03)00041-4 · Cited by 69
Tomàs, M., Sentı́, M., Elosúa, R., Vila, J., Sala, J., Masià, R., & Marrugat, J. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01482-0 · Cited by 68
James, R. W., Blatter, M.-C., Calabresi, L., Miccoli, R., von Eckardstein, A., Tilly-Kiesi, M., Taskinen, M., Assmann, G., & Franceschini, G. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00058-6 · Cited by 66
Self-citationde Roos, N. M., Schouten, E. G., Scheek, L. M., van Tol, A., & Katan, M. (2002) · Metabolism · doi:10.1053/meta.2002.36305 · Cited by 56
Paraoxonase 1 Activity: A New Vascular Marker of Dementia?
DANTOINE, T. F., Debord, J., Merle, L., LACROIX‐RAMIANDRISOA, H., Bernard‐Bourzeix, L., & Charmes, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04802.x · Cited by 55
Voetsch, B., Benke, K. S., Panhuysen, C. I. M., Damasceno, B. P., & Loscalzo, J. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.351 · Cited by 54
Arrol, S., Mackness, M., & Durrington, P. N. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00353-6 · Cited by 53
Wallace, A. J., Sutherland, W. H. F., Mann, J. I., & Williams, S. (2001) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601250 · Cited by 52
Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: correlation with glycemic control
Sözmen, B., Akçay, Y., Girgin, F. K., & Sözmen, E. Y. (1999) · Clinical Biochemistry · doi:10.1016/s0009-9120(99)00034-x · Cited by 48
Kopprasch, S., Pietzsch, J., Kuhlisch, E., & Graessler, J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021561 · Cited by 45
Scacchi, R., Gambina, G., Martini, M. C., Broggio, E., Vilardo, T., & Corbo, R. M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01437-4 · Cited by 42
Leviev, I., Kalix, B., Meynet, M.-C. B., & James, R. W. (2001) · Diabetologia · doi:10.1007/s001250100610 · Cited by 39
Self-citationThe effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease
Paragh, G., Seres, I., Harangi, M., Balogh, Z., Illyés, L., Boda, J., Szilvássy, Z., & Kovacs, P. L. (2003) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70077-0 · Cited by 39
Pola, R., Gaetani, E., Flex, A., Gerardino, L., Aloi, F., Flore, R. A., Serricchio, M., Pola, P., & Bernabei, R. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000067975 · Cited by 36
Barbieri, M., Bonafè, M., Marfella, R., Ragno, E., Giugliano, D., Franceschi, C., & Paolisso, G. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8183 · Cited by 36
Paraoxonase 1 gene polymorphisms and dementia in humans
Helbecque, N., Cottel, D., Codron, V., Berr, C., & Amouyel, P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2003.12.100 · Cited by 36
Deakin, S., Leviev, I., Nicaud, V., Brulhart‐Meynet, M., Tiret, L., & James, R. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.3.1268 · Cited by 35
Self-citationSerhatlıoğlu, S., Gürsu, M. F., Gülcü, F., et al. (2003) · Cell Biochemistry and Function · doi:10.1002/cbf.1042 · Cited by 29
Association of Paraoxonase 1 Polymorphism With Beta-Cell Function
Chiu, K. C., Chuang, L., Chu, A. Y., Lu, J., Hu, J., & Fernando, S. (2004) · Pancreas · doi:10.1097/00006676-200405000-00021 · Cited by 20
Effect of six candidate genes on early aging in a French population
Xia, Y., Gueguen, R., Vincent‐Viry, M., Siest, G., & Visvikis‐Siest, S. (2003) · Aging Clinical and Experimental Research · doi:10.1007/bf03324487 · Cited by 17
Cited by
Beltowski, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.003 · Cited by 483
Quorum-quenching microbial infections: mechanisms and implications
Dong, Y.-H., Wang, L.-H., & Zhang, L.-H. (2007) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2007.2045 · Cited by 362
Mackness, M., & Mackness, B. (2015) · Gene · doi:10.1016/j.gene.2015.04.088 · Cited by 310
Lou-Bonafonte, J., Gabás-Rivera, C., Navarro, M., & Osada, J. (2015) · Nutrients · doi:10.3390/nu7064068 · Cited by 64
Potential role of anti-inflammatory HDL subclasses in metabolic unhealth/obesity
Tang, H., Xiang, Z., Li, L., Shao, X., Zhou, Q., You, X., Xiong, C., Ning, J., Chen, T., Deng, D., et al. (2021) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.1080/21691401.2021.1961798 · Cited by 27
Metadata
- Authors
- DEAKIN, S. P., & JAMES, R. W.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2004-10-26
- Volume
- 107
- Issue
- 5
- Pages
- 435-447
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1981302306
- Cited by
- 267
- References
- 93
- FWCI
- 7.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.